Epigenomics Market
According to Intent Market Research, the Epigenomics Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 23.5% to touch USD 56.7 billion by 2030. The Epigenomics Market is dominated by key players such as Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Merck & Co., Inc., Roche Diagnostics, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., New England Biolabs, Inc., Promega Corporation, PerkinElmer, Inc., Bio-Techne Corporation, Zymo Research Corporation, Abcam PLC.